News Roundup: September 26 to September 30
Your weekly roundup of the latest news from Drug Topics®.
Supporting the Next Era of Independent Pharmacies in the US & Abroad
The future of independent pharmacy requires the combination of what makes independent pharmacy special and the digital landscape found elsewhere in retail.
Update on Using Dextromethorphan-Bupropion in Depression
A new—cough, cough—combination treatment for depression. Researchers performed an RCT of dextromethorphan-bupropion in major depressive disorder.
Is There a Link Between COVID-19 and Increased Type 1 Diabetes Diagnoses?
A pair of studies released within days of one another have produced conflicting reports related to the apparent increase in type 1 diabetes diagnoses following a COVID-19 infection in younger patients.
Program for Safer Opioid Supply Shows Positive Results
Positive effects emerge when patients get medical care, avoid deadly fentanyl-laced street drugs.
Adjustments in Drug Coverage Criteria in Health Plans Based on New Evidence
However, researchers found that only a small percentage of plans use available real-world evidence studies and economic evaluations in their coverage policies.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
